Also trades as: 4DX.AX (ASX) · $vol 17M
FDMDF OTC
4DMedical Limited
1W: +9.1%
1M: +1.7%
3M: +7.1%
YTD: +27.7%
1Y: +129.0%
3Y: +1251.3%
$3.00
+0.25 (+9.09%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$7M
+20.5% ▲
5Y CAGR: +100.6%
Gross Profit
-$38M
-805.6% ▼
Operating Income
-$57M
-96.4% ▼
Net Income
-$204M
-578.9% ▼
EPS (Diluted)
$-0.03
+78.6% ▲
EBITDA
-$52M
-12.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $1M | $719K | $3M | $6M | $7M |
| YoY Growth | +385.9% | -31.8% | +324.4% | +91.9% | +20.5% |
| Cost of Revenue | $774K | $25M | $237K | $464K | $45M |
| Gross Profit | $281K | -$24M | $3M | $5M | -$38M |
| Gross Margin | 26.6% | -3378.6% | 92.2% | 92.1% | -539.2% |
| R&D Expenses | $3M | $8M | $694K | $3M | $144K |
| SG&A Expenses | $19M | $25M | $30M | $32M | $19M |
| Operating Expenses | $22M | $20M | $49M | $35M | $19M |
| Operating Income | -$22M | -$31M | -$47M | -$29M | -$57M |
| Operating Margin | -2105.8% | -4265.8% | -1528.4% | -499.2% | -813.7% |
| Interest Expense | $180K | $294K | $264K | $0 | $3M |
| Income Before Tax | -$25M | -$31M | -$36M | -$30M | -$210M |
| Tax Expense | $43K | $323K | $48K | $87K | -$6M |
| Net Income | -$25M | -$31M | -$36M | -$30M | -$204M |
| Net Margin | -2332.6% | -4378.0% | -1179.8% | -513.7% | -2895.1% |
| EPS (Diluted) | $-0.08 | $-0.10 | $-0.10 | $-0.14 | $-0.03 |
| EBITDA | -$35M | -$44M | -$32M | -$46M | -$52M |
| Shares Outstanding | 295M | 300M | 370M | 424M | 6.81B |